Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.8%

42 terminated/withdrawn out of 388 trials

Success Rate

82.5%

-4.1% vs industry average

Late-Stage Pipeline

26%

102 trials in Phase 3/4

Results Transparency

12%

23 of 198 completed trials have results

Key Signals

38 recruiting23 with results30 terminated12 withdrawn

Enrollment Performance

Analytics

N/A

155(48.4%)

Phase 3

63(19.7%)

Phase 2

45(14.1%)

Phase 4

39(12.2%)

Phase 1

12(3.8%)

Early Phase 1

6(1.9%)

320Total

N/A(155)

Phase 3(63)

Phase 2(45)

Phase 4(39)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (388)

Showing 20 of 388 trials

NCT03439228Not ApplicableRecruiting

To Brace or Not to Brace for Single Level Lumbar Fusion Pilot

Role: lead

NCT05873881Phase 3Recruiting

COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

Role: lead

NCT07533864Recruiting

ACSS Approach on Dysphagia

Role: lead

NCT06605144Phase 3Recruiting

Canadian Critical Care Comparative Effectiveness Platform

Role: collaborator

NCT06979284Not ApplicableRecruiting

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Role: lead

NCT07828964Not ApplicableNot Yet Recruiting

The BRAVE (Behaviourally Responsive Assessments of Vital Signs in Emergency) Study

Role: lead

NCT05963698Not ApplicableRecruiting

The Fourth Left Atrial Appendage Occlusion Study

Role: lead

NCT04284839Phase 3Recruiting

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Role: collaborator

NCT03636295Phase 3Recruiting

Low INR to Minimize Bleeding With Mechanical Valves Trial

Role: collaborator

NCT07027436Phase 3Recruiting

Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.

Role: lead

NCT06908694Phase 4Active Not Recruiting

Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

Role: lead

NCT05994625Phase 3Active Not Recruiting

Economic Evaluation of Stream™ Platform

Role: collaborator

NCT03825965Phase 3Completed

Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT

Role: collaborator

NCT04661787Completed

Donation Advisor Clinical Decision Support Tool Study

Role: collaborator

NCT05866458Recruiting

Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

Role: collaborator

NCT04090710Phase 2Completed

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer

Role: collaborator

NCT04797299Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

Role: collaborator

NCT06203977Phase 2Completed

Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)

Role: lead

NCT03020303Phase 3Completed

Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Role: lead

NCT02907255Not ApplicableCompleted

Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery

Role: collaborator